BioCentury
ARTICLE | Clinical News

Amsterdam Molecular preclinical data

June 7, 2010 7:00 AM UTC

In mice, a single IV dose of AMT-110 reduced serum cholesterol by about 80% with no signs of toxicity. Additionally, AMT-110 led to prolonged gene silencing of apolipoprotein B-100 (APOB-100) with no...